drugset / Trial / NCT05755191
A Study to Assess NEU-411 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose (SAD), food effect (FE),multiple ascending dose (MAD), drug-drug interaction study, and bioavailability - bio-equivalence study of orally administered NEU-411 in healthy subjects
Timeline
- Start
- 2023-05-13
- Primary completion
- 2024-06-03
- Completion
- 2024-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NEU-411 | Small molecule | — | Oral |
Indications
No indication recorded.